Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Cash from Operations (2024 - 2025)

Profound Medical has reported Cash from Operations over the past 2 years, most recently at 6566000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 6566000.0 for Q4 2025, down 11.69% from a year ago — trailing twelve months through Dec 2025 was 38207000.0 (down 62.91% YoY), and the annual figure for FY2025 was 38207000.0, down 62.91%.
  • Cash from Operations for Q4 2025 was 6566000.0 at Profound Medical, up from 9614000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for PROF hit a ceiling of 4529000.0 in Q1 2024 and a floor of 13744000.0 in Q2 2025.